Artisan Partners’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,407,713
Closed -$14.7M 351
2025
Q1
$14.7M Sell
4,407,713
-134,455
-3% -$448K 0.02% 292
2024
Q4
$33.6M Sell
4,542,168
-261,657
-5% -$1.94M 0.05% 257
2024
Q3
$45.1M Sell
4,803,825
-307,584
-6% -$2.89M 0.07% 230
2024
Q2
$41M Sell
5,111,409
-26,813
-0.5% -$215K 0.06% 238
2024
Q1
$76.1M Buy
5,138,222
+310,552
+6% +$4.6M 0.11% 174
2023
Q4
$39.2M Sell
4,827,670
-208,809
-4% -$1.7M 0.06% 226
2023
Q3
$22.9M Buy
5,036,479
+609,738
+14% +$2.77M 0.04% 242
2023
Q2
$31.2M Buy
4,426,741
+858,035
+24% +$6.04M 0.05% 236
2023
Q1
$21.8M Buy
3,568,706
+832,974
+30% +$5.09M 0.04% 249
2022
Q4
$17.5M Sell
2,735,732
-22,841
-0.8% -$146K 0.03% 259
2022
Q3
$26.4M Sell
2,758,573
-20,229
-0.7% -$194K 0.05% 241
2022
Q2
$30.7M Buy
2,778,802
+66,788
+2% +$737K 0.05% 236
2022
Q1
$45.2M Buy
2,712,014
+24,284
+0.9% +$404K 0.06% 236
2021
Q4
$51.3M Sell
2,687,730
-180,565
-6% -$3.45M 0.06% 239
2021
Q3
$70.7M Sell
2,868,295
-106,039
-4% -$2.61M 0.09% 216
2021
Q2
$77.4M Sell
2,974,334
-8,780
-0.3% -$228K 0.09% 203
2021
Q1
$94.4M Buy
2,983,114
+79,645
+3% +$2.52M 0.12% 173
2020
Q4
$135M Buy
2,903,469
+71,231
+3% +$3.31M 0.16% 137
2020
Q3
$93.2M Sell
2,832,238
-157,915
-5% -$5.2M 0.13% 153
2020
Q2
$82.1M Buy
2,990,153
+1,188,943
+66% +$32.6M 0.13% 152
2020
Q1
$53.9M Buy
1,801,210
+156,093
+9% +$4.67M 0.12% 167
2019
Q4
$45.5M Buy
1,645,117
+432,569
+36% +$12M 0.08% 189
2019
Q3
$22.1M Buy
1,212,548
+177,152
+17% +$3.22M 0.04% 230
2019
Q2
$25.4M Buy
+1,035,396
New +$25.4M 0.05% 220